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It has previously been shown that in patients convalescent from 
pneumococcus lobar  pneumonia the intradermal injection  of  type- 
specific capsular polysaccharide (S.S.S.)  elicits  a  typical  cutaneous 
reaction (1, 2).  The reaction takes the form of an immediate wheal 
and erythema which reaches its height within 15  to 30 minutes.  It 
can first be elicited at or about the time of recovery.  The reaction is 
type-specific  in that it is produced only by the polysaccharide homolo- 
gous in type to that of the infecting organism.  Furthermore, in the 
small  series  previously reported,  it  was  noted  that  recovery from 
Type I  pneumonia in serum-treated cases was invariably associated 
with the development  of a positive skin reactivity to the Type I  S.S.S., 
whereas approximately  only 50  per  cent of  the non-serum-treated 
Type II and Type III cases which recovered gave a specific response 
to  the homologous S.S.S.  (2).  The occurrence of the reaction was 
found to be intimately associated with the presence of type-specific 
antibodies in  the patient's  serum.  In  cases  treated  with  Type  I 
antipneumococcus serum, it was observed that although type-specific 
antibodies might be present in the blood of the patients, the skin test 
remained negative.  When, however, the skin test became positive, 
recovery invariably ensued. 
These observations suggested that in patients suffering from Type 
I pneumococcus  pneumonia the skin test with Type I  S.S.S. might be 
a valuable guide in determining when serum therapy could be safely 
discontinued.  The present report,  therefore, comprises an analysis 
* Presented,  in part,  before the American Society for Clinical Investigation at 
a meeting held in Atlantic City, May 4, 1931. 
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of the results of skin  tests with  Type I  S.S.S.  obtained  in a  series of 
53 cases of Type I pneumococcus pneumonia, 48 of which were treated 
with antipneumococcus Type I  serum. 
Materials  and  Methods 
The patients were among those admitted to the wards of the Hospital of The 
Rockefeller Institute with a  diagnosis  of lobar pneumonia.  Their ages ranged 
from 6 years to 70 years.  The pneumococcus typings were done by use of the 
Avery tube, as well as by the usual method of inoculating the sputum of the patient 
into the peritoneal cavity of a mouse, and the subsequent macroscopic agglutina- 
tion and precipitation reactions with peritoneal washings  of the mouse.  Blood 
cultures were made on admission and at varying intervals thereafter.  Except in 
the 5 instances noted, all patients were treated with unconcentrated Type I anti- 
pneumococcus horse serum obtained from the New York State Board of Health. 
Specific treatments consisted in the intravenous administration every 6 to 8 hours 
of 100 cc. of serum diluted with an equal volume of physiological saline. 
Skin Test.--Protein-free type-specific capsular polysaccharides were prepared by 
the methods employed in this laboratory (4)  and were of the highest degree of 
purity  obtainable.  The  polysaccharides  were  dissolved  in  physiological  salt 
solution, and 0.1  cc. of solution containing 0.01 rag.  of the S. S. S. was injected 
intradermaUy.  In the earlier tests, S. S. S. of Types I, II, and III were separately 
injected into the skin of the forearm together with a saline control.  In the present 
study of reactions in patients with Type I pneumonia, only the Type I S. S. S. and 
a saline control have been used. 
The skin tests, during the course of treatment, were done 6 to 8 hours following 
each administration of serum, since it is known that after this interval the passively 
introduced antibodies may have been removed from the blood (5).  Following each 
intradermal test, the inoculated sites were observed carefully for 20 to 30 minutes. 
A positive reaction was recorded in the presence of erythema, edema, wheal, and 
pseudopodia.  Frequently, itching of the skin at the site of reaction was noted by 
the patient.  Concomitantly, the elevation of the skin at the point of the control 
saline injection tends to disappear. 
Circulating Antibodies.--The  presence of type-specific  agglutinins for Type I 
Pneumococcus was demonstrated in the patient's serum by the method previously 
described  (2). 
The data included in this report comprise the results obtained by 
repeatedly testing the  skin  reaction  to  Type I  S.S.S.  in  53  patients 
during the  course of lobar pneumonia associated with Type I  Pneu- 
mococcus.  In 48 of the cases specific serum therapy was  employed. 
In the  series are included  7  fatal cases,  5  cases with  empyema,  and 
others with furuncles, sterile pleural effusions, and delayed resolution. THOMAS  FRANCIS~  JR.  619 
The  5  untreated  patients  were  comparatively mild  cases which  re- 
covered  spontaneously.  A  summary  of  the  cutaneous  reactions  of 
Type I  S.S.S. in these 53 patients is presented in Table I. 
The uniformity of results is surprisingly sharp for a biological test. 
From Table I it is readily seen that of the 45 cases in which a  positive 
skin  reaction  was  obtained,  all  recovered.  Of  the  8  patients  with 
negative reactions,  only 1 survived.  This exception, the failure of a 
recovered patient  to  react,  occurred  in  a  negro  with  empyema,  in 
whom only a doubtful reaction was seen.  Further, of the other 4  cases 
of empyema tested after the acute stage of the pneumonia had passed, 
all gave typical positive reactions, and all recovered. 
TABLE  I 
The Results  of Skin  Tests  with Type I  Polysaccharide  in  Type I  Pneumococcus 
Pneumonia 
Patients 
,erum-treated 
Tntreated. 
Total. 
:mpyemat. 
No. of 
cases 
48 
5 
53 
Positive reactions 
Recovered  Died  Recovered 
40  0 
5  0 
45  0 
4 
Negative reactions 
Died 
1"  7 
1  7 
1 
* Empyema with doubtful reaction. 
~f Included also under serum-treated cases. 
Included amongst the  7 fatal  cases is  1 case which had  a  Type I 
pneumonia with septicemia, from which recovery apparently  ensued 
with normal temperature,  sterile blood, and definite and nearly com- 
plete resolution.  The  skin  test  remained  negative,  and the patient 
suddenly had a  recurrence of pneumonia and septicemia, this time a 
Type III pneumococcus infection, which proved fatal. 
A  brief  summary  and  graphic  representation  of illustrative  cases 
serve to  emphasize  the  time  relationships  between  the  onset of re- 
covery and the occurrence of the skin reactions, with reference to the 
presence of circulating antibodies in the blood of convalescent cases. 
Furthermore,  in the fatal cases, it will be seen that in spite of sterili- 620  SKIN TEST IN[ PNEUMOCOCCUS  PNEUMONIA 
zation of the blood, the presence of circulating antibodies, and sympto- 
matic improvement,  the skin reaction remained negative.  The fact 
that the skin test, under these conditions, is negative, dearly shows 
Key to Charts 1 to 6 
Skin Tests.--Broken line = negative reaction.  Wavy line = doubtful reaction. 
Cross-hatched bar = positive reaction. 
Aggluffnins.--Dash  =  no demonstrable  agglutinins.  Black  bar  ~,  highest 
positive dilution. 
f Indicates  fatal termination. 
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C-~ARZ 1.  Patient  S  (Hospital No.  7152). 
without septicemia. 
I[ 
Type I pneumococcus pneumonia 
that  positive reactions are not simply dependent upon the humoral 
type-specific antibodies,  and  that  cutaneous reactivity is not  solely 
referable to the passive immunity conferred by the administration  of 
the specific antibodies. TIIOMAS  ]~RANCIS,  JR.  621 
Patient  1,  Chart  1,  Case  7152 
The patient, a housewife of 32 years, was admitted  to the hospital on the 3rd 
day of illness, with lobar pneumonia of the right middle lobe.  On admi.~sion, the 
blood culture was negative, the blood contained no agglutinins for Type I  Pneumo- 
coccus, and the skin test with Type I S. S. S. was negative.  Type I  antipneumo- 
coccus serum was first administered  10 hours  after admission.  8  hours  later, 
Type I  S. S. S. elicited  only a questionable skin reaction, since an erythema also 
occurred at the site of the control saline injection.  Although the temperature had 
begun to fall, a second treatment was given, and a precipitate drop of temperature 
took place.  A skin test done 8 hours after the last serum treatment was markedly 
positive, and the patient's serum at this time contained a  comparatively high titre 
of type-specific antibodies.  Convalescence  was uneventful. 
This  case  illustrates  the  ordinary  rapid  termination  of  the  acute 
course of disease, and the development of cutaneous reactivity at the 
time of recovery. 
Patient  2,  Chart  2,  Case  7263 
The patient, a man, 34 years of age, was admitted to the hospital on the 3rd day 
of illness,  with lobar pneumonia of the right lower lobe.  On admission, a blood 
culture revealed Type I Pneumocoecns in the circulating blood; the patient's serum 
contained  no  demonstrable  type-specific antibodies;  and  the  type-specific skin 
test was negative.  Serum therapy was begun 6 hours after  admission.  After 
the second treatment, a  fall of temperature occurred.  A skin test done at this 
time was negative.  The temperature rose again just before the fourth treatment. 
The skin  test was negative, a blood culture was sterile, and type-specific aggluti- 
nins  were not demonstrable in the patient's blood.  A skin test before the sixth 
treatment was negative, but 6 hours later a  definitely positive skin reaction was 
elicited with S. S. S. I, and  circulating  antibodies  were  present.  Although  the 
patient's temperature was 102 °, serum therapy was discontinued.  The following 
morning the temperature was normal, and an uninterrupted recovery ensued. 
This case illustrates the value of the skin test in instances in which 
the  temperature is  swinging,  and  in  which  it  is  important  to  know 
whether  recovery  has  begun  or  whether  the  fall  of  temperature  is 
only  a  remission.  The  negative  skin  test  indicates  further  serum 
therapy.  Furthermore,  when the positive reaction was obtained,  in 
spite of the fact that fever was still present, it was shortly followed by 
a  normal temperature.  This case also emphasizes the  fact that  the 
antibodies passively introduced through serum treatment may not be 
detectable in the circulating blood 6 to 8 hours after the  treatment, or 
even after several treatments. 622  SKIN  TEST IN PNE~OCOCCUS  PNEUMONIA 
CHART 2.  Patient  P.  (Hospital No. 7263).  Type I  pneumococcus pneumonia 
and septicemia. 
Patient  3,  Chart  3,  Case 7165 
The patient, a housewife of 30 years, was admitted to the hospital on the 2nd 
day of illness, suffering from lobar pneumonia of the left lower lobe.  At the time 
of admission,  the blood culture was  positive for Type I  lhaeumococcus.  The 
patient's serum contained no demonstrable type-specific antibodies, and the Type 
I  skin test was negative.  After two doses of serum,  the blood became sterile, 
type-specific antibodies were present in  the blood, but  the skin test remained 
negative.  The pneumonic process spread to involve the left upper lobe.  Serum 
was  repeatedly  administered,  agglutinins persisted in  the blood, but  repeated 
skin tests were consistently negative.  On the 6th day, after nine doses of serum, 
although no change in the patient's general condition was noted, a  positive skin 
reaction was elicited.  This was construed as indicative of recovery.  The titre 
of circulating antibodies had not increased above that found on the 3rd and 4th THOMAS  FRANCIS, JR.  623 
days, when the skin test was negative.  Nevertheless, serum was discontinued, 
and 48 hours later, on the 8th day, the temperature dropped to normal.  Conva- 
lescence was uneventful. 
The significant points exemplified by this case are that  although 
type-specific antibodies were present in the patient's blood after two 
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C~_A~T 3.  Patient H. (Hospital No. 7165).  Type I pneumococcus  pneumonia 
and septicemia. 
serum treatments, the pulmonary lesion was spreading and the skin test 
remained negative.  When the skin test became positive, no increase 
in  antibody  titre  occurred,  nor  had  any definite  objective  change 
occurred in  the patient's  condition.  Experience suggested that  re- 
covery would  follow the positive  reaction,  and  that  was  the  case. 
The occurrence of a  positive test is obviously in  this  case not due 624  SKIN  TEST  IN  PNEUMOCOCCUS PNEUMONIA 
simply to  the presence of circulating antibodies, but  is  associated 
definitely  with+the complicated process of recovery. 
Patient  4,  Chart  4,  Case  7219 
The patient, an advertising man of 52 years, was admitted to the hospital on the 
6th day of disease, suffering from lobar pneumonia of the left lower lobe, left upper 
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CHART 4.  Patient  Sc. (Hospital No. 7219). 
and septicemia. 
lobe, and right lower lobe.  He was extremely sick.  The blood culture on admis- 
sion yielded Type I Pneumococcus.  There were no type-specific antibodies in the 
blood.  The skin reaction was negative.  Serum therapy was inaugurated 2 hours 
after admission, and continued at 6 hour intervals for five doses.  After the second 
dose, agglutinins were demonstrated  in the blood, and  these  increased progres- 
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sively to a high titre.  The blood became sterile by the 7th day, and remained 
sterile till death.  The temperature dropped to normal on the 8th day, and signs 
of resolution were heard over the left lower lobe.  But the type-specific skin test 
remained negative throughout.  The patient  alternated between delirium and 
stupor, and finally succumbed on the 10th day.  At autopsy, massive pneumonic 
involvement of the left lung with beginning  resolution,  and consolidation  of the 
right lower lobe,  were found.  Chronic  nephritis, interstitial purulent hepatitis, 
and pancreatitis were also observed. 
In this instance, it is clearly seen that cutaneous reactivity may be 
the only indication that recovery is not occurring.  Normal tempera- 
ture,  pulse,  and  respirations,  negative  blood  cultures,  high  titre  of 
antibodies,  and  physical  signs  of  resolution  were  present,  but  the 
additional factors which play a r61e in the production of a positive skin 
test were absent.  Whether additional serum therapy would have been 
of aid is problematical, but on the basis of present experience it would 
be considered advisable. 
Patient 5,  Chart 5,  Case 7162 
The patient, a man of 27, was admitted to the hospital on the 2nd day of illness, 
suffering from lobar pneumonia of the left lower lobe.  On admission, blood cul- 
ture yielded a Type I Pneumococcus;  no type-specific agglutinins  were present in 
the patient's serum; the skin  test  with  Type I  S.S.S.  was  negative.  Serum 
treatment was begun 7 hours after admission, and continued at 6 to 8 hour inter- 
vals.  Mter the second  treatment, type-specific  antibodies were present in the 
blood, increased in titre, and remained present throughout the iUness.  The blood 
culture became negative and remained so until the day of death, when it became 
positive again.  The pneumonic process continued to spread in the face of circu- 
lating antibodies and sterile blood so that the entire left lung and the right lower 
and upper lobes became involved.  Cyanosis became extreme, although the pa- 
tient was in the oxygen chamber.  The skin tests were repeatedly and consistently 
negative.  Eleven doses of serum were given, but death intervened on the 6th day. 
No autopsy was permitted. 
This case presents another instance in which the serological findings 
would be considered favorable.  Although circulating antibodies were 
present in  a  good titre,  the skin  tests were all negative.  The same 
lack of response has been consistently noted in the fatal cases of the 
series. 626  SKIN  TEST  IN PNEUMOCOCCUS  PNEUMONIA 
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CHART 5.  Patient Mo. (Hospital No. 7162).  Type I pneumococcus pneumonia 
and septicemia. 
Patient 6,  Chart  6,  Case 7580 
The patient, a negro of 35, was admitted to the hospital on the 6th day of dis- 
ease, with lobar pneumonia of the right lower lobe, and left lower and upper lobes. 
He was extremely sick.  The blood culture was positive, no circulating Type I 
agglutinins were detectable, the skin test was negative.  Serum therapy was insti- 
tuted 8 hours after admission.  After the second treatment, the temperature was 
lower, the blood culture in broth was sterile, no circulating agglutinins were demon- 
strable, and the skin test remained negative.  On the 8th day, after the fifth and 
sixth treatments, skin tests were still negative, but a high titre of agglutinins was 
present, and although the temperature was normal, the patient remained danger- 
ously ill, in delirium, and the septicemia had increased in degree.  Although it was 
not known until later that the septicemia had increased, serum therapy was con- 
tinued because of the negative skin test.  On  the 9th day the temperature re- THOMAS  fRANCIS,  JR.  627 
mained at about the normal level, the blood culture had become sterile,  but the 
skin test elicited a  response so faint that it could only be considered doubtful. 
The following day a  s~mihr result was obtained.  After the  10th day, delirium 
ceased and the patient improved somewhat.  Convalescence  was delayed by the 
development of an encapsulated empyema, which  was drained by operation on 
the 25th day. 
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CHART 6.  Patient Mu. (Hospital No. 7580). 
with septicemia and empyema. 
Type I pneumococcus pneumonia 
This case is the one exception in the entire series of 53  patients in 
that it is the only instance in which a  patient, at or about the time of 
recovery from the acute phase of pneumonia, failed to give a  distinctly 
positive skin test.  It is also the only case without a definitely positive 
reaction which did not have a fatal termination.  On the 9th and 10th 
days,  reactions were observed which  were considered suggestive.  It 628  SKIN  TEST IN PNELr~OCOCCUS  PNEUMONIA 
is possible that in the skin of a negro the milder forms of reaction are 
more difficult to detect.  At any rate, on the 8th day, 18 hours before 
it was known  that  septicemia had increased, with the  temperature 
normal and type-specific agglutinins present in the blood, the value of 
the negative skin test in indicating further treatment must be stressed. 
This case is also exceptional in that it remains the only 1 of the 5 cases 
of empyema, all  of which recovered, that  failed to  give  a  positive 
reaction at the termination of the phase of acute pneumonia. 
DISCUSSION 
The results of the skin tests with Type I S.S.S. in 53 cases of Type 
I pneumococcus pneumonia are strikingly uniform for a biological test. 
In the series there were 7 deaths, in all of which repeated skin tests were 
negative.  On the other hand, in 46 recovered cases, including 5 cases 
of empyema, all but 1 gave a positive reaction at about the time of 
recovery from the acute pulmonary process.  In the one exception, a 
negro with subsequent  empyema, only a  doubtful reaction was ob- 
tained although the patient recovered (Patient 6, Chart 6).  Exem- 
plary individual cases have been cited to show the relation of positive 
reactions to recovery and to the presence of antibodies in the circulat- 
ing blood.  Furthermore, they emphasize the fact that the mere pres- 
ence of circulating antibodies,  in  cases before recovery or in  cases 
terminating fatally, is not  sufficient to  bring about  a  positive  skin 
reaction. 
Finland and Sutliff, in similar studies, reported only 7 positive tests 
to the Type I  S.S.S. in a series of 15 non-serum-treated patients who 
recovered from Type I  pneumonia (3).  Of 17 Type I  and  Type II 
cases tested before the time of crisis,  3  gave positive  tests  to  the 
homologous polysaccharide.  Moreover, the relation of positive skin 
tests to recovery and to the presence of type-specific antibodies in the 
blood was corroborated.  Of the fatal cases in their untreated series, 
only 1 of ll  cases of all three types gave a  positive reaction.  The 
details of this case are not recorded. 
In their cases which were treated with serum (6), two distinct differ- 
ences from the procedures employed by us must  be noted.  In the 
first place, Felton's concentrated serum containing Type I  and Type 
II  antibodies  was  used.  Secondly,  the  skin  tests  were frequently THOMAS FRANCIS,  JR.  629 
made within 1 to 2 hours after the administration of serum.  Never- 
theless, 20 of 23 Type I  and Type II serum-treated cases which re- 
covered gave positive skin reactions, while of 5  treated cases which 
terminated fatally, 1 gave a positive result. 
In the present series of cases treated with Type I  serum, a positive 
skin test has always been indicative of recovery, and in only 1 instance 
did recovery occur in the absence of a positive skin reaction.  In all 
these cases, circulating type-specific antibodies were demonstrable at 
the  time  a  positive  cutaneous  test  was  first  obtained.  However, 
reference to charts of Patients 3, 4, and 5, reveals that a positive test 
is not simply referable to  a  high  concentration of circulating anti- 
bodies, since the titre of antibodies may be the same before recovery 
when the skin test is negative, as it is later when a positive test occurs. 
These charts also show that, in fatal cases, although antibodies may be 
present in  the blood,  a  positive  skin  test  is  not obtained.  Conse- 
quently, it appears that cutaneous reactivity to S.S.S. is not merely 
dependent upon the presence of circulating type-specific antibodies. 
On  the other hand,  its  development  is  always associated with  the 
presence of these antibodies in the blood.  These observations indicate 
that for positive cutaneous reactivity there are required both active 
tissues and specific antibodies homologous in type to that of the S.S.S. 
injected, and that absence of either factor results in failure to react. 
Recovery from pneumonia is a complicated process in which cellular 
activities play an important  r61e.  This is  strikingly demonstrated 
in the study of resolution of pneumonia.  A positive skin test to S.S.S. 
is also invariably associated with recovery, and it is suggested that this 
reaction may be an indicator of a general reawakening of cellular activ- 
ity in the presence of type-specific antibodies.  The failure to obtain 
a  positive reaction in fatal cases, or in cases before recovery begins, 
even when type-specific antibodies are present, may be attributable to 
a depression of general cellular activity by the toxic factors of disease. 
This interpretation is supported by the observation of Finland and 
Sutliff (6) that when a Type I patient is treated with serum containing 
both Type I  and Type II antibodies, the skin test to Type II S.S.S. 
does not become positive before the Type I  S.S.S. skin test, although 
Type II antibodies have been present in relatively high titre through- 
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The value of the skin test as employed in the present group of cases 
appears to be definitely established both as a guide to serum therapy 
and as a prognostic aid.  In certain instances, by the time a typing of 
the invading organism is obtained, the patient appears improved and 
the temperature may have approached a normal level.  There may be 
some doubt as to whether treatment with serum is required.  A skin 
testwith the S.S.S. may be done, and the result read in 15 to 30 minutes; 
a negative test indicates serum therapy.  In all cases of this sort,  the 
conclusions reached as a result of the skin test have been validated by 
subsequent findings and the course of disease.  Similarly, in cases with 
intermittent fever, or in which a  drop of temperature follows  serum 
therapy, the skin test gives a distinct answer to the problem of whether 
recovery has begun or whether treatment should be continued (Charts 
1 to 3).  A  positive reaction is invariably, in our experience, a sign 
that recovery  will follow.  Furthermore, although the patient may still 
appear quite sick with little change from a previous period when the 
skin test was negative, the development of a positive cutaneous reac- 
tion indicates recovery and that further serum therapy is unnecessary 
(Chart 3).  A persistently negative reaction, even in the presence of 
circulating  antibodies,  clinical  improvement,  and  continued  serum 
therapy, offers an unfavorable prognosis,  and in  all  cases has  been 
associated with a  fatal termination (Charts 4  and 5).  To repeat, a 
positive immediate wheal and erythema reaction to Type I  S.S.S in 
cases  of  Type  I  pneumococcus  pneumonia predicates  recovery; a 
negative test calls for further serum therapy. 
It has been assumed that the chief function of antipneumococcus 
serum as  a  therapeutic agent is  to  furnish type-specific antibodies. 
Consequently, the presence or absence of type-specific agglutinins in 
the patient's blood has been employed as a means of estimating when 
sufficient serum has been administered.  The application of titration 
of circulating agglutinins in conjunction with the use of concentrated 
serum has been recently advanced by Sabin (7).  From the point of 
view of recovery, however, it furnishes an estimate of only the humoral 
aspect.  In Patient 3, Chart 3, type-specific agglutinins were demon- 
strable  in  the  patient's  blood  although  the  pneumonic  lesion  was 
spreading.  Later when the skin test became positive, the agglutinins 
were present in the same concentration.  In Charts 4 and 5 are shown THOMAS YI~CIS, JR.  631 
examples of the occurrence of agglufinins in cases terminating fatally 
and in which the skin test, by remaining consistently negative, prog- 
nosticated the fatal outcome.  In Chart 6, a good titre of agglutinins 
was present although the septicemia was increasing.  The skin test 
became only doubtfully positive at time of recovery, but this may have 
been due in part to the fact that the skin of the negro made the result 
more difficult to read.  When a positive cutaneous reaction has been 
obtained, however, recovery  has always ensued.  As additional advan- 
tages,  the  skin  test  has  simplicity of technic, the results are easily 
read, it is rarely equivocal, the answer is obtained in 15 to 30 minutes, 
the results have been remarkably regular, and it apparently measures 
the  resultant  of antibody and  tissue  activity.  The  results of this 
study appear to establish the value of the skin test with Type I  S.S.S. 
in the serum treatment of Type I pneumococcus pneumonia. 
SUMM~RY  AND  CONCLUSIONS 
Skin tests were made with Type I  S.S.S. in 53 cases of Type I pneu- 
mococcus lobar pneumonia, 48 of which were treated with antipneumo- 
coccus Type I serum.  In all but 1 of the 46 recovered cases a positive, 
immediate skin reaction was obtained at about the time of recovery. 
In 7 fatal cases reactions were consistently negative, even in the pres- 
ence of circulating type-specific antibodies. 
The skin test has proved to be an extremely valuable guide to serum 
therapy, and a  definite prognostic aid.  The test has distinct advan- 
tages over the agglutination reaction in that it is not merely an index of 
circulating  antibodies.  When  positive,  it  invariably  denotes that 
recovery has begun; when negative, it indicates further serum therapy. 
The mechanism of the positive  skin test  is  closely related to  that 
operative in recovery from pneumonia, and is apparently the resultant 
of antibody and tissue activity. 
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